Diana Elbourne

Statistics and Probability · 2001–2019

A researcher in the Science corpus: 13 papers; trusts 11 researchers and is trusted by 21 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 111 citations into it; #2,103 of 12,932 by trust here, #239 by citations
• Economics and Econometrics — 66 citations into it; #3,363 of 23,481 by trust here, #610 by citations
• Public Health, Environmental and Occupational Health — 34 citations into it; #878 of 2,368 by trust here, #270 by citations
• General Health Professions — 29 citations into it

Whom Diana Elbourne trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. David Moher
2. Douglas G. Altman
3. K. F. Schulz
4. John P. A. Ioannidis
5. G. Piaggio
6. Sander Greenland
7. S. Evans
8. M. Campbell

Who trusts Diana Elbourne overall

1. K. F. Schulz
2. Douglas G. Altman
3. David Moher
4. Gunther Eysenbach
5. Sally Hopewell
6. Myron D. Ginsberg
7. E. von Elm
8. G. Piaggio
9. Kosuke Imai
10. Stuart J. Pocock

Papers from Diana Elbourne's perspective

Ordered by how strongly the researchers Diana Elbourne trusts endorse each paper. Same corpus, a different order for every researcher.

1. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (Medical Journal of Australia)
2. A comparison of observational studies and randomized, controlled trials. (New England Journal of Medicine)
3. Principles of multilevel modelling. (International Journal of Epidemiology)
4. What is missing from descriptions of treatment in trials and reviews? (British medical journal)
5. Vasopressin versus norepinephrine infusion in patients with septic shock. (New England Journal of Medicine)
6. Optimal medical therapy with or without PCI for stable coronary disease. (New England Journal of Medicine)
7. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
8. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (New England Journal of Medicine)
9. Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates (New England Journal of Medicine)
10. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. (The Lancet)

Their papers

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) — 6,841 citations
• The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001) — 3,977 citations
• CONSORT statement: extension to cluster randomised trials (2004) — 2,119 citations
• Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. (2006) — 997 citations
• Meta-analyses involving cross-over trials: methodological issues. (2002) — 1,557 citations
• Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. (2006) — 1,902 citations
• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012) — 3,604 citations
• Consort 2010 statement: extension to cluster randomised trials (2012) — 2,133 citations
• CONSORT 2010 statement: extension to randomised crossover trials (2019) — 675 citations
• CONSORT 2010 statement: extension checklist for reporting within person randomised trials (2017) — 286 citations
• Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects (2014) — 2,514 citations
• Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. (2009) — 2,726 citations
• Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. (2005) — 1,004 citations